Many animal cells release ATP into the extracellular medium, and often this release is mechanosensitive. However, the mechanisms underlying this release are not well understood. Using the luciferin-luciferase bioluminescent assay we demonstrate that a Xenopus oocyte releases ATP at a basal rate ϳ0.01 fmol/s, and gentle mechanical stimulation can increase this to 50 fmol/s. Brefeldin A, nocodazole, and progesterone-inducedmaturation block basal and mechanosensitive ATP release. These treatments share the common feature of disrupting the Golgi complex and vesicle trafficking to the cell surface and thereby block protein secretion and membrane protein insertion. We propose that ATP release occurs when protein transport vesicles enriched in ATP fuse with the plasma membrane. Collagenase, integrin-binding peptides, and cytochalasin D also block ATP release, indicating that extracellular, membrane and cytoskeletal elements are involved in the release process. Elevation of intracellular Ca 2؉ does not evoke ATP release but potentiates mechanosensitive ATP release. Our study indicates a novel mechanism of mechanotransduction that would allow cells to regulate membrane trafficking and protein transport/secretion in response to mechanical loading.
Many, if not all, animal cells release ATP (or UTP) into the extracellular medium, and often this release is MS 1 (1) (2) (3) (4) (5) (6) . External ATP acts on ATP receptors that regulate diverse functions, including pain and touch sensation, smooth muscle contractility, synaptic transmission, platelet aggregation, epithelial fluid secretion, and endothelial release of vasorelaxants (6 -8) . Furthermore, abnormalities in ATP release may contribute to specific human diseases, most notably cystic fibrosis (9) . Although several mechanisms have been proposed to contribute to ATP release, including synaptic vesicular release and various membrane ion channels (10 -16) , the mechanism of MS ATP release remains unknown.
Our interest in MS ATP release was stimulated by the discovery of Nakamura and Strittmatter (1) that mechanical stimulation of the Xenopus oocyte evokes ATP release without causing an increase in membrane conductance. Here, we test the hypothesis that ATP release from the oocyte is mediated by the high rate (4,000 -16,000/s) of membrane fusion of vesicles involved in transporting proteins from the Golgi complex to the cell surface (17) . This idea seemed plausible given the identification of a specific ATP transporter that concentrates ATP in the Golgi/ER lumen 50 -100-fold above that in the cytoplasm (18, 19) . To test the hypothesis we have examined the effects of BFA and other treatments that are known to disrupt membrane trafficking and thereby block protein secretion (20 -22) .
A key issue for any MS process is the pathway by which mechanical forces are transmitted to that process. For example, specific membrane channel proteins in bacteria and animal cells respond directly to tension developed in the lipid bilayer (23) , while other MS processes may be activated by forces transmitted via elements of the ECM and/or CSK (i.e. tethers), possibly interconnected by integrins (24) . In the case of the MG cation channel endogenous to the Xenopus oocyte, a bilayer model is favored, because the channel retains its mechanosensitivity in CSK-deficient plasma membrane vesicles (25) . However, because of the oocyte's large excess membrane area (i.e. Ͼ500%) in the form of membrane folds and microvilli, even large oocyte deformations (e.g. caused by inflation, aspiration, or fluid jet stimulation) fail to increase membrane conductance (26) . In contrast, the mildest deformation of the oocyte will activate ATP release (1, 27) . This difference may arise because MS ATP release involves a tethered mechanism, perhaps analogous to the integrin-dependent, stretch-sensitive transmitter release at the frog neuromuscular junction (28) . To test this possibility, we have examined the effects of integrin-binding peptides, as well as specific agents that disrupt ECM and CSK elements.
EXPERIMENTAL PROCEDURES
The preparation of oocytes from Xenopus frogs was as described previously (29) . After surgical removal, the oocytes were incubated in Barth's solution, typically containing 1 mg/ml collagenase Type II (Sigma) for 5 h on a rocker platform at room temperature. In some cases, oocytes were not treated with collagenase or were treated for longer duration (i.e. ϳ15 h). Defolliculated oocytes were allowed to recover in Barth's solution for ϳ36 h at 17°C. Experiments were performed on stage VI oocytes usually 2-4 days after isolation.
ATP released from individual oocytes was monitored using the luciferin-luciferase bioluminescence assay in a luminometer (2010 Monolight, PharMingen). The ATP monitoring concept (30) assumes that during the measurement the luciferase activity remains constant and degrades only a tiny fraction of the total ATP present (i.e. Ͻ1% min
Ϫ1
). Because the ATP is consumed by the luciferase enzyme on a millisecond time scale, any change in ATP is registered immediately. In our experiments, the luminometer cuvette typically contained 140 l of ND-96 buffer (in mM: 96 NaCl, 2 KCl, 1 MgCl 2 , 1.8 CaCl 2 , 5 NaHepes, pH 7.8) and 10 l of the Sigma ATP assay reagent (1 mg/ml luciferin-luciferase mix). The assay was calibrated by plotting the log of luminescence * This work was supported by the National Institutes of Health and by Muscular Dystrophy Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ To whom correspondence should be addressed: Physiology and Biophysics, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77550-0641. Tel.: 409-772-5464; Fax: 409-772-3381; Email: ohamill@utmb.edu. 1 The abbreviations used are: MS, mechanosensitive; BFA, brefeldin A; MG, mechanically gated; ECM, extracellular matrix; ER, endoplasmic reticulum; CSK, cytoskeleton; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid; AM, acetoxymethyl ester. intensity (relative luminescence units) against the log of ATP concentration (moles/liter) using the Sigma ATP calibration standards. For both calibration and oocyte experiments, we measured the ATP-induced light over a 15 s sampling periods. The background light was measured and subtracted by running a blank. The ATP-induced light was converted to moles of ATP according to the calibration plot prepared each day. All treatments directly tested on ATP release were first screened for effects on assay sensitivity.
The measured ATP from an oocyte should reflect the balance between the rates of ATP release and hydrolysis. However, the ectoATPase activity of the oocyte is associated with the follicular cells and can be inhibited by collagenase treatment (31) . Under these conditions any basal ATP release should result in ATP accumulation and a timedependent increase in bioluminescence. To measure basal ATP release we gently aspirated an individual oocyte into the tip (ϳ2 mm diameter) of a Pasteur pipette and transferred it to the luminometer cuvette. Measurements were then made every minute for at least 15 min. To evoke MS ATP release the oocyte was stimulated in the cuvette using a Gilson micropipettor with a P200 pipette tip to repetitively "puff" 120 l of the buffer at the oocyte. Special care was taken not to directly touch or aspirate the oocyte into the tip. For each mechanical stimulation three buffer puffs were applied over approximately a 3-s duration. The rate of MS ATP release was estimated by dividing the increment in ATP level (measured immediately after stimulation) by the duration of the mechanical stimulation. To estimate the cytoplasmic ATP concentration, the oocyte was ruptured by repetitive aspiration into the tip of the puffer pipette.
The chemicals ATP, BAPTA.AM, A23187, BFA, cytochalasin D, progesterone, and nocodazole were from Sigma; gadolinium (III) chloride hexahydrate was from Aldrich; apyrase (200 units, 140 units/mg) was from Fluka; and the peptides: GRGESP RGD (Gly-Arg-Gly-Glu-SerPro, inactive), GRGDSP RGD (Gly-Arg-Gly-Asp-Ser-Pro, anti-fibronectin-anti-vitronectin), GRGDdSP (Gly-Arg-Gly-Asp-D-Ser-Pro, selective anti-fibronectin), and GPenGRGDSPCA RGD (Gly-Pen-Gly-Arg-GlyAsp-Ser-Pro-Cys-Ala(cyclical), where Pen indicates penicillamine), selective anti-vitronectin) were from Life Technologies, Inc. The concentration and incubation time for the different drugs used were as follows: 5 g/ml BFA for 2.5 h, 0.2 mM integrin-binding peptides for 1.5 h, 0.25 M cytochalasin D for 2 h, 10 M BAPTA.AM or 10 M GdCl 3 for 45 min. To facilitate the effect of nocodazole (see Ref. 32) , oocytes were previously exposed to cold treatment (i.e. 1 h in ND-96 on ice in the cold room) and then incubated in 20 M nocodazole for 1 h at 17°C. Control experiments indicated that cold treatment alone did not block either basal or MS ATP release. A23187 was added to the cuvette to give a final concentration of 10 M. Apyrase was also directly added to the cuvette (4 units in 2 l, from a stock 140 units/mg). Stage VI oocytes were matured in vitro by incubation in ND-96 plus 10 M progesterone for ϳ12 h. Maturation was judged by the appearance of a white spot on the animal pole (33) . In zero-calcium experiments, ND-96 minus CaCl 2 was prepared in plastic beakers and used in the buffer/assay mixture. Oocytes were gently washed several times in the same medium before testing.
RESULTS
Fig . 1A shows ATP calibration curves measured in control (ND-96), 100 M Gd 3ϩ , and hypotonic (ND-33) solutions. 100 M Gd 3ϩ reduced assay sensitivity, whereas ND-33 increased it. Fig. 1B illustrates an experiment simulating ATP release. In the standard buffer/assay solution the background luminescence was ϳ100 relative luminescence units (i.e. same as the blank) and equivalent to 2 fmol of added ATP. Repetitive applications of 15-fmol aliquots of ATP produced a staircase increase in luminescence, and addition of apyrase abolished the response. Fig. 2A indicates that the initial transfer of the oocyte to the cuvette (i.e. at time 0) increased the base-line equivalent to adding ϳ20 fmol of ATP, which was followed by a steady increase of ϳ10 amol/s (8.6 Ϯ 0.05 ϫ 10 Ϫ18 mol/s). In comparison, addition of non-collagenase-treated oocytes did not increase the luminescence above background, while addition of oocytes treated overnight (i.e. 15 versus 5 h) with collagenase showed a relatively larger increase in basal ATP release (Table  I) . These results confirm a previous study (31) that indicated follicle-enclosed oocytes express significant ecto-ATPase activity, and this activity is inhibited by collagenase. We believe the initial increase in ATP level at zero time may be due in part to inadvertent mechanical stimulation of the oocyte during the transfer because it is reduced along with MS ATP release (see Fig. 3 ). possibly reflecting a reduction in the MS releasable pool and/or assay sensitivity (c.f. Fig. 1B ). Note this apparent saturating response to gentle mechanical stimulation was ϳ4 orders of magnitude less than the ATP released by mechanical damage of the oocyte (see below). Mechanical rupture of the oocyte increased the luminescence equivalent to 300,000 fmol of ATP, which decayed rapidly in the first minute, presumably due to ATP hydrolysis by released/activated ATPase. Addition of apyrase further reduced the ATP-generated luminescence.
Several mechanisms may contribute to ATP release, and different mechanisms may underlie basal and MS release. For example, the oocyte expresses hemi-gap and Gd 3ϩ -sensitive MG channels, both of which have been implicated in ATP release from epithelial cells (12, 15) . However, mechanical stimuli much stronger than that required to cause ATP release, fails to activate a membrane conductance increase (1, 26, 27) . Furthermore, 10 M Gd 3ϩ , which completely blocks hemi-gap and MG channel activity (33, 34) , does not affect ATP release (Table I) . 100 M Gd 3ϩ caused an apparent, partial inhibition of ATP release (data not presented), but this may be due to the higher Gd 3ϩ reducing assay sensitivity (see Fig. 1A ). It has recently been proposed that strong hyperpolarization of the oocyte (i.e. to Ϫ200 mV) may activate an ATP-selective conductance (16) . However, our studies indicate similar hyperpolarizations activate a nonselective conductance that fails to saturate with prolonged hyperpolarization and recovers only slowly (i.e. Ͼ10 min) following repolarization (34) . These properties are consistent with reversible membrane dielectric breakdown. Whatever the underlying mechanism, this voltageactivated conductance does not mediate the non-electrogenic MS ATP release measured at resting potentials (1).
Non-electrogenic ATP release could be mediated by exocytosis, a specific ATP transporter or both. To test the hypothesis that ATP release is associated with fusion of protein carrier vesicles with the plasma membrane, we examined the effects of different agents that disrupt the Golgi complex and thereby block membrane/protein trafficking. BFA reversibly blocks anterograde vesicular transport through a redistribution of the Golgi complex into the ER (22) and thereby inhibits protein secretion from animal cells, including the Xenopus oocyte (35, 36) . We found that BFA treatment also blocks basal and MS release (Table I, Fig. 3B ), and the block is reversed 3 h after removal of BFA (data not presented). Progesterone maturation of the oocyte is associated with the disappearance of the Golgi apparatus and block of protein secretion (37) . We found that basal and MS ATP release is also absent in matured oocytes (Fig. 3C , Table I ). The microtubule network is critical in maintaining the integrity and function of the Golgi complex (38) , and its depolymerization by nocodazole disrupts the Golgi complex and vesicle trafficking (39) . We found that nocodazole also blocks basal and MS ATP release (Table I , Fig. 3E ), and this block was reversed within 3 h after nocodazole exposure (data not presented). The above treatments did not alter the normal oocyte resting membrane potential (ϳϪ30 mV) nor the amount of ATP released upon oocyte rupture (i.e. ϳ3 nM) (data not presented). To determine the pathway by which mechanical forces are transmitted to the ATP release process, we tested specific agents that interfere with ECM, membrane, and CSK elements. Evidence for ECM involvement was indicated by prolonged exposure of oocytes to collagenase (i.e. 15 versus 5 h), which blocked MS ATP release by 99% (Table I ). In contrast, basal ATP release appeared enhanced (i.e. 129%, see Table I ), probably because prolonged collagenase exposure produces a more complete inhibition of ecto-ATPase activity. To determine whether ECM-integrin interactions are important in ATP release, we tested specific RGD-containing peptides that disrupt integrin binding to ECM proteins (24, 28) . We found that the peptide (GRGDdSP), which inhibits integrin binding to fibronectin, but not to vitronectin, significantly reduced basal and MS ATP release (Fig. 3D , Table I ). The nonspecific antifibronectin-anti-vitronectin peptide (GRGDSP) produced a similar effect (data not presented). However, neither the specific anti-vitronectin peptide (GPenGRGDSPCA) ( Table I) nor an inactive control peptide (GRGESP) inhibited ATP release (data not presented). Because integrins mechanically link the ECM to the actin CSK (24), we tested the effect of disruption of actin microfilaments. We found that treatment of oocytes with cytochalasin D blocked both basal and MS release (Fig. 3F , Table  I ). The selective block of MS ATP release by collagenase indicates that basal ATP release can proceed even when ECM elements critical for mechanosensitivity are disrupted. However, intact integrin and microfilament interactions are apparently required for basal ATP release. These interactions may be involved in transmitting background mechanical forces (i.e. arising from gravity and/or CSK tension) that modulate the release mechanism.
We found that external Ca 2ϩ was not required for basal or MS ATP release (Figs. 4, A and B) . Furthermore, 10 M A23187 did not stimulate ATP release. However, A23187 treatment consistently potentiated (ϳ10-fold) MS ATP release (Fig. 4C , Table I ). The A23187 potentiation was blocked when measured in zero-Ca 2ϩ external solution (data not shown) and by preincubation of the oocyte in 10 M BAPTA-AM (Fig. 4D) . We also tested A23187 on progesterone matured oocytes, which causes massive cortical granule-membrane fusion, in addition to activating the Ca increase ATP release (data not presented), indicating that cortical granules do not contain ATP and Ca 2ϩ -activated Cl Ϫ channels do not mediate ATP efflux (see also Fig. 4C ).
DISCUSSION
The Xenopus oocyte belongs to a growing list of animal cells that exhibit MS ATP (or UTP) release (1) (2) (3) (4) (5) (6) . Here, we provide new details on a novel mechanism that may explain why basal and MS ATP release is a general feature of animal cells. In summary, MS ATP release can occur without membrane damage based on its reversible block by specific agents (e.g. BFA, nocodazole, and integrin-binding peptides) and irreversible block by progesterone-induced maturation. It is also not mediated by the endogenous MG, hemi-gap, or Ca 2ϩ -activated Cl Ϫ channels. Instead, we propose that (i) ATP release is dependent upon BFA-sensitive trafficking of ATP-enriched vesicles that transport protein from the Golgi to the cell surface, (ii) the vesicle trafficking and/or membrane fusion is facilitated by mechanical forces transmitted from the ECM to the CSK possibly via membrane integrins, (iii) increase in [Ca 2ϩ ] i acts cooperatively with mechanical forces to promote ATP release, and (iv) progesterone maturation of the oocyte blocks ATP release, implying that ATP release may play some role in the normal maintenance of the follicle and/or immature oocyte.
The Xenopus oocyte releases ATP at a basal rate of around 0.01 fmol/s, and gentle mechanical stimuli can transiently increase this 5,000-fold to 50 fmol/s. In comparison, mechanical rupture of the oocyte results in the release of 300,000 fmol of ATP. This indicates a cytoplasmic ATP concentration of around 1 mM (i.e. for an oocyte volume ϳ0.5 l). However, this is likely an underestimate of the actual concentration given the rapid degradation of released ATP by activated ATPase activity (Fig.  2B) . Furthermore, this estimate does not include ATP compartmentalized within mitochondria and the ER/Golgi cisternae. Clearly, the basal and MS-released ATP represents a tiny fraction of the total oocyte ATP.
According to our primary hypothesis, both basal and MS ATP release arise from fusion/exocytosis of vesicles involved in transporting proteins from the Golgi complex to the cell surface. This hypothesis is supported by the block of ATP release by BFA, nocodazole, and progesterone-induced maturation of the oocyte. All three treatments cause disappearance of the Golgi complex and thereby block protein transport/secretion from the Xenopus oocyte (20 -22, 36, 38) . According to Zampighi et al. (17) , the vesicles that transport proteins to the cell surface fuse with the cell membrane at a rate of at least 4,000 s . This concentration is only ϳ5 times higher than the estimated cytoplasmic concentration and is reasonable given the identification of a specific ATP transporter that can concentrate ATP in the Golgi/ER lumen 50 -100 times above that in external medium (18, 19) . Presumably, the ATP released reflects the residual ATP left in the vesicle after ATP-dependent processing of cargo proteins is complete (18) . Although we currently favor ATP release by exocytosis, our luminescence measurements cannot exclude the possibility that block of membrane trafficking does not also inhibit membrane insertion of electroneutral ATP transporters. However, even if some resident Golgi ATP transporters reach the cell membrane (i.e. despite Golgi retention mechanisms, see Ref. 40) , in order for them to mediate ATP efflux they would require obligatory ADP/AMP influx (18, 41) . In this case, conditions that reduced local external ADP/AMP (e.g. block of ecto-ATPase activity or buffer puffs directed at the surface) would be expected to reduce rather than increase ATP efflux (c.f. Table I) . Furthermore, because BFA block of ATP release is Ͼ95% complete within 2.5 h, it would imply the hypothesized membrane-inserted ATP transporters have a membrane half-life of less than 1 h. In comparison, the measured half-life of membrane proteins expressed in oocytes ranges between 4 and 36 h (17, 42, 43) .
It is possible that the ATP released from the oocyte plays no additional functional role but merely represents the unavoidable consequence/cost of requiring ATP in the Golgi/ER lumen as a substrate and energy source for processing secretory and membrane-bound proteins (18, 44, 45) . The absence of endogenous ATP receptors on the oocyte (e.g. see Ref. 1) would seem to rule out any autocrine signaling role. However, it is possible that released ATP activates endogenous ATP receptors on follicular cells (e.g. see Ref. 46 ) and thereby participates in a regulatory cell-cell loop involving the electrically coupled oocyte and follicular cells (47) . In this case, changes in external "mechanical tone" exerted on the oocyte by the surrounding follicular cell layer may regulate MS ATP release. It has been shown that direct oocyte inflation or oocyte aspiration can induce ATP release as monitored by purinergic receptors heterologously expressed in the oocyte (1). However, our preliminary results indicate that osmotic swelling of the oocyte (i.e. in ND-33) does not significantly increase ATP release. 2 The demonstration that the BFA-sensitive process that mediates constitutive protein secretion and membrane protein insertion is mechanosensitive has implications beyond the oocyte. For example, this process may serve as a general intrinsic mechanism for regulating animal cell growth and proliferation in response to mechanical loading. At least consistent with this idea is the demonstration that stretch-induced hypertrophy of isolated cardiac myocytes is mediated by increased release of angiotensin II (48) and that mechanical strain-induced proliferation of fetal lung cells is associated with increased constitutive release of glycosaminoglycans and proteoglycans (49) . It is also interesting that MS ATP release from the oocyte shares some similarities with stretch-induced enhancement of transmitter release at the frog NMJ (28) . For example, both MS processes are blocked by integrin-binding peptides, and both can occur when elevation of [Ca 2ϩ ] i is prevented (Ref. 28 and Fig. 4D ). However, whereas elevation of [Ca 2ϩ ] i alone can evoke synaptic transmitter release, it only serves to facilitate MS ATP release. This facilitation may be related to the demonstrated Ca 2ϩ dependence of vesicle fusion during intra-Golgi transport (50) . Finally, our results provide possible clues to the mechanism underlying CFTR-dependent ATP release from specific cell types (see Ref. 51) . For example, cAMP activation of CFTR has been shown to be associated with a sustained increase in ATP release (33 fmol/s) from CFTR-transfected oocytes (13) but not from CFTR-expressing Calu-3 cells (4). Interestingly, in CFTR-transfected Xenopus oocytes (as well as in human epithelial cells) it has been demonstrated that cAMP activation of CFTR occurs mainly by increased membrane insertion of new CFTR channels (52) (53) (54) , whereas in other cell types, including Calu-3 cells, cAMP directly activates already inserted CFTR channels (55, 56) . Furthermore, BFA and nocodazole block CFTR activation in the former cell type (53) but not the latter (56) . A plausible explanation for these cell typespecific effects is that CFTR confers cAMP sensitivity on membrane trafficking and thereby ATP release.
In conclusion, our study reveals a novel mechanism of mechanotransduction that involves ATP release via BFA-sensitive vesicle trafficking between the Golgi complex and the cell surface. Since this mechanism is common to most animal cells, it would explain why constitutive ATP release is widespread in animal cells (57) . The idea that the process that determines constitutive protein secretion and membrane protein insertion is MS has implications for MS regulation of cell growth and development. This process may also account for why overexpression or activation of specific membrane proteins (e.g. CFTR) in some cells has been associated with increased ATP release.
